机构:[1]Singapore Eye Research Institute, Singapore, Singapore[2]Singapore National Eye Center, Singapore, Singapore,[3]Division of Human Genetics, Genome Institute of Singapore, Singapore, Singapore,[4]Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA,[5]Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan[6]Department of Ophthalmology,Kyoto Prefectural University of Medicine, Kyoto, Japan[7]Department of Medical Statistics, Kyoto Prefectural University of Medicine, Kyoto, Japan,[8]Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Centre, Beijing Tongren Hospital, Capital Medical University, Beijing, China,首都医科大学附属北京同仁医院首都医科大学附属同仁医院[9]Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical School, Fudan University, Shanghai, China[10]State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Fudan University, Shanghai, China,[11]Department of Ophthalmology, Yong Loo Lin School of Medicine,[12]SawSwee Hock School of Public Health, National University of Singapore, Singapore, Singapore,[13]Duke-NUS Graduate Medical School, Singapore, Singapore,[14]Department of Ophthalmology and Visual Sciences, The Chinese Uuniversity of Hong Kong Eye Hospital, Hong Kong, China,[15]Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Seoul Korea,[16]National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology, London, UK,[17]SNONGC Department of Genetics and Molecular Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, India,[18]Department of Integrative Genomics, Tohoku Medical Megabank Organization, Sendai, Japan,[19]Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia,[20]Department of Ophthalmology, College of Medicine, University of Florida, Jacksonville, FL, USA,[21]Chinese University of Hong Kong Joint Shantou International Eye Center, Shantou University, Shantou, China,[22]Department of Genetics, Aravind Medical Research Foundation, Madurai, Tamilnadu, India,[23]Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia,[24]Department of Ophthalmology, Flinders University, Adelaide, Australia,[25]Department of Genetics and Computational Biology, Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia,[26]Sichuan Provincial Key Laboratory for Human Disease Gene Study, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’s Hospital, Chengdu, China,四川省人民医院[27]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,四川省人民医院[28]Ozaki Eye Hospital, 1–15, Kamezaki, Hyuga, Miyazaki 883-0066, Japan,[29]Mizoguchi Eye Hospital, 6-13 Tawara-machi, Sasebo, Nagasaki 857- 0016, Japan,[30]Glaucoma Services, Aravind Eye Hospital, Madurai, Tamilnadu, India,[31]Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia,[32]Vietnam National Institute of Ophthalmology, Hanoi, Vietnam,[33]Ophthalmology Department, Angers University Hospital, Angers, France[34]Biochemistry Department, Angers University Hospital, Angers, France,[35]Department of Ophthalmology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,华中科技大学同济医学院附属同济医院[36]Huntingdon Glaucoma Diagnostic & Research Centre, Hinchingbrooke Hospital, Huntingdon, UK,[37]Norfolk & Norwich University Hospital NHS Trust, Norwich, UK,[38]Heart of UK NHS Foundation Trust, Birmingham, UK,[39]School of Medicine, Dentistry and Biomedical Sciences, Centre for Experimental Medicine, Queen’s University Belfast, Northern Ireland, UK,[40]Department of Medicine, Duke University Medical Center, Durham, NC, USA,[41]Department of Cellular Biology and Anatomy, Georgia Regents University, Augusta, Georgia,[42]Medical Research Foundation, Sankara Nethralaya, Chennai, India,[43]Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Heidelberg, Germany,[44]Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA[45]Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA,[46]State Key Laboratory of Oncology in Southern China, Guangzhou, China,[47]Department of Experimental Research, Sun Yat-Sen University Cancer Centre, Guangzhou, China,[48]Clinical Research Unit, Oxford University, 190 BenHamTu,Ho Chi Minh City, Vietnam,[49]Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford OX3 7LJ, UK,[50]Department of Epidemiology and Biostatistics, CaseWestern Reserve University, Cleveland, OH, USA,[51]Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA, USA,[52]Department of Medicine, National University Health System & National University of Singapore, Singapore,[53]Einhorn Clinical Research Center, Department of Ophthalmology, New York Eye and Ear Infirmary, New York, NY, USA,[54]Eye Doctors of Washington DC, Washington, DC, USA,[55]Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA, USA,[56]Centre for Eye Research Australia (CERA), University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia,[57]Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, AL, USA,[58]Centre for Ophthalmology and Visual Science, Lions Eye Institute, University ofWestern Australia, Perth,WA, Australia,[59]Myopia Key Laboratory of the Ministry of Health of China, Shanghai, China[60]Chinese Academy of Sciences, Sichuan Translational Medicine Hospital, Chengdu, China
Primary open angle glaucoma (POAG), a major cause of blindness worldwide, is a complex disease with a significant genetic contribution. We performed Exome Array (Illumina) analysis on 3504 POAG cases and 9746 controls with replication of the most significant findings in 9173 POAG cases and 26 780 controls across 18 collections of Asian, African and European descent. Apart from confirming strong evidence of association at CDKN2B-AS1 (rs2157719 [G], odds ratio [OR] = 0.71, P = 2.81 x 10(-33)), we observed one SNP showing significant association to POAG (CDC7-TGFBR3 rs1192415, ORG-allele = 1.13, P-meta = 1.60 x 10(-8)). This particular SNP has previously been shown to be strongly associated with optic disc area and vertical cup-to-disc ratio, which are regarded as glaucoma-related quantitative traits. Our study now extends this by directly implicating it in POAG disease pathogenesis.
基金:
The
Singapore study of E.N.V., T.A. and C.C.K was supported by a Biomedical
Research Council (BMRC) grant in Singapore, Ref: BMRC
10/1/35/19/675. This research was also partly supported by a
grant (NMRC/TCR/008-SERI/2013) from the Singapore National
Research Foundation under its Translational and Clinical
Research Flagship Programme and administered by the Singapore
Ministry of Health’s National Medical Research Council.
We also acknowledge the following source of funding support
for recruitment and genotyping of population-based cohorts
SIMES and SCES: National Medical Research Council, Singapore
(NMRC/TCR/002-SERI/2008, (R626/47/2008TCR), CSA R613/34/
2008, NMRC 0796/2003, STaR/0003/2008), the National Research
Foundation of Singapore, the Biomedical Research Council,
Singapore (BMRC 09/1/35/ 19/616 and 08/1/35/19/550) and Genome
Institute of Singapore (GIS/12-AR2105). The Singapore Tissue
Network and the Genome Institute of Singapore, Agency for
Science, Technology and Research, Singapore provided services.
The research of M.A.H. was supported by NIH R01 EY023646,
EY13315 (MAH) and by P30-EY005722. The Japanese sample collection
from Kyoto was supported by the grants from the Collaborative
Development of Innovative Seeds of Japan Science and
Technology Agency (JST) to M.K. and K.T., from the Ministry of
Health, Labor and Welfare of Japan to M.N., K.M., K.T. and S.K.,
and from Santen Pharmaceutical Co. Ltd. to S.K. and K.T. The collection
of Japanese POAG cases by N.F. was supported by a grant
provided by the Ministry of Health, Labor and Welfare of Japan.
The glaucoma research of WNL is supported by National Natural
Science Foundation of China project (81030016). The research of
Y. Chen was supported by National Natural Science Foundation
of China (81200723) and glaucoma research of Xinghuai Sun
was supported by Special Scientific Research Project of Health
Professions (201302015). This research project was supported by
the National Natural Science Foundation of China (81170883
(Z.Y.) and 81430008 (Z.Y.)). The glaucoma research of C.P.P. is supported
by the Health and Medical Research Fund (HMRF, Ref:
01122236 and 11120801), Hong Kong and the General Research
Fund from the Research Grants Council (grant number 468810),
Hong Kong. Support for recruitment of Australian & NewZealand
Registry of Advanced Glaucoma (ANZRAG) was provided by the
Royal Australian and New Zealand College of Ophthalmology
(RANZCO) Eye Foundation. Genotyping was funded by the
National Health and Medical Research Council of Australia
(#535074 and #1023911). This workwas also supported by funding
from NHMRC #1031362 awarded to Jamie E. Craig, NHMRC
#1037838 awarded to Alex W. Hewitt, NHMRC #1048037 awarded
to Stuart L. Graham, NHMRC #1009844 awarded to Robert
J. Casson and Ivan Goldberg, NHMRC #1031920 and an Alcon
Research Institute grant awarded to David A. Mackey, an Allergan
Unrestricted grant awarded to Andrew J. White, the BrightFocus
Foundation and a Ramaciotti Establishment Grant. S.M. is supported
by Australian Research Council (ARC) and Australian National
Health & Medical Research Council (NHMRC) Fellowships.
Controls for the ANZRAG discovery cohort were drawn from the
Australian Cancer Study, the Study of Digestive Health, and
from a study of inflammatory bowel diseases. The Australian
Cancer Study was supported by the Queensland Cancer Fund
and the National Health and Medical Research Council
(NHMRC) of Australia (Program no. 199600, awarded to David
C. Whiteman, Adele C. Green, Nicholas K. Hayward, Peter G. Parsons, David M. Purdie and Penelope M.Webb, and program
number 552429, awarded to David C. Whiteman). The Study of
Digestive Health was supported by grant number 5 RO1 CA
001833 from the National Cancer Institute (awarded to David
C. Whiteman). The Barrett’s and Esophageal Adenocarcinoma
Genetic Susceptibility Study (BEAGESS) sponsored the genotyping
of oesophageal cancer and Barrett’s oesophagus cases,
which were used as unscreened controls in the ANZRAG discovery
cohort. BEAGESS was funded by grant R01 CA136725 from the
National Cancer Institute Collection of Saudi POAG cases and
controls was supported by the Glaucoma Research Chair at College
of Medicine, King Saud University, Riyadh, Saudi Arabia.
NEI Glaucoma Human Genetics Collaboration (NEIGHBOR):
genotyping services for the NEIGHBOR study were provided by
the CIDR and were supported by the NEI through grant
HG005259-01 (J.L.W.). Additionally, CIDR is funded through a federal
contract fromthe NIH to The Johns Hopkins University, contract
number HHSN268200782096C. Collecting and processing
samples for the NEIGHBOR data set was supported by the NEI
through American Recovery and Reinvestment Act (ARRA) grants
3R01EY015872-05S1 (J.L.W.) and 3R01EY019126-02S1 (M.A.H.).
Genotype imputation and meta-analysis were supported by
EY022305 (J.L.W.). Funding for the collection of cases and controls
was provided by the following NIH grants: EY015543 (R.R. Allingham);
EY006827 (D. Gaasterland); HL73042, HL073389, EY13315,
EY023646 (M.A.H.); CA87969, CA49449, UM1 CA167552 (J.H.
Kang); EY009149 (P.R. Lichter); HG004608 (C. McCarty); EY008208
(F.A. Medeiros); EY015473 (L.R.P.); EY012118 (M. Pericak-Vance);
EY015682 (A. Realini); EY011671, EY09580 (J.E. Richards);
EY013178 (J.S. Schuman); RR015574, EY015872, EY010886,
EY009847, EY014104 (J.L.W.); EY011008, EY144428, EY144448 and
EY18660 (K. Zhang). J.L.W. and L.R.P. are also supported by the
Harvard Glaucoma Center for Excellence and Research to Prevent
Blindness. J.N.C.B. is supported by NIH T32 EY007157 (CWRU) and
T32 EY21453-2 (VUMC). MEEI case-control sample: genotyping for
the Massachusetts Eye and Ear Infirmary (MEEI) case-control
sample was performed at the Broad Institute of MIT and Harvard
with funding support fromthe NIH GEI (Gene Environment Initiative)
(U01HG04424 and U01HG004728). The GENEVACoordinating
Center (U01HG004446) assisted with genotype cleaning. Imputation
was supported by NIH EY022305 (JLW). Collection of cases
and controls was supported by NIH EY015872 (JLW) and NIH P30
014104 (JLW). Funding to pay the Open Access publication charges
for this article was provided by Singapore Eye Research Institute.
第一作者机构:[1]Singapore Eye Research Institute, Singapore, Singapore[3]Division of Human Genetics, Genome Institute of Singapore, Singapore, Singapore,
共同第一作者:
通讯作者:
通讯机构:[1]Singapore Eye Research Institute, Singapore, Singapore[3]Division of Human Genetics, Genome Institute of Singapore, Singapore, Singapore,[11]Department of Ophthalmology, Yong Loo Lin School of Medicine,[13]Duke-NUS Graduate Medical School, Singapore, Singapore,[*1]The Academia, 20 College Road, Discovery Tower level 6, Singapore 169856, Singapore.[*2]60 Biopolis Street, #02-01 Genome Building, Genome Institute of Singapore, Singapore 138672, Singapore.
推荐引用方式(GB/T 7714):
Zheng Li,R. Rand Allingham,Masakazu Nakano,et al.A common variant near TGFBR3 is associated with primary open angle glaucoma[J].HUMAN MOLECULAR GENETICS.2015,24(13):3880-3892.doi:10.1093/hmg/ddv128.
APA:
Zheng Li,R. Rand Allingham,Masakazu Nakano,Liyun Jia,Yuhong Chen...&NEIGHBORHOOD Consortium.(2015).A common variant near TGFBR3 is associated with primary open angle glaucoma.HUMAN MOLECULAR GENETICS,24,(13)
MLA:
Zheng Li,et al."A common variant near TGFBR3 is associated with primary open angle glaucoma".HUMAN MOLECULAR GENETICS 24..13(2015):3880-3892